2026 Speakers
- Jun Bao
- Founder & Managing Partner
- APURI BIOVENTURE
- Tess Cameron
- Managing Director
- RA CAPITAL
- Cyber Cao
- Managing Director
- HSG
- Anna Chen
- Partner
- FRAZIER LIFE SCIENCE
- Claire Chen
- Managing Director
- HANKANG CAPITAL
- Cynthia Chen
- Chairlady
- PULNOVO MEDICAL
- Kan Chen
- Partner
- QIMING VENTURE PARTNERS
- Michael Chen
- Chief Business Officer
- DARWIN BIOTECHNOLOGY
- Cui Cui
- Managing Director, Head of Asia Healthcare Research
- JEFFERIES
- Paul Cui
- Director, Business Operation, Greater China
- IQVIA
- Dandan Dong
- Venture Partner
- TCGX
- Jianmin Fang
- Co-Founder & Chief Executive Officer
- REMEGEN BIOSCIENCE
- Lei Fang
- Co-Founder，Chairman & Chief Executive Officer
- EXCALIPOINT THERAPEUTICS
- Jun Feng
- Chief Executive Officer
- ENCHANNEL MEDICAL
- Yan Feng
- Chief Executive Officer
- Leadingtac Pharmaceuticals
- Yun Gao
- Principal
- LILLY ASIA VENTURES
- Sheng Han
- Vice Director, International Research Center of Medicinal Administration
- PEKING UNIVERSITY
- Nanhai He
- Vice President, Global Drug Discovery
- ADLAI NORTYE
- Wei Hu
- Chief Executive Officer
- ATTEC BIOTECHNOLOGY
- Xiangbo Jia
- Chairman & Chief Executive Officer
- BIOCITY PHARMACEUTICS
- Jerry Lee
- Global Chair of Investment Banking
- JP MORGAN
- Bin Li
- Founder and Chief Investment Officer
- LAKE BLEU CAPITAL
- James Li
- Venture Partner
- FRAZIER LIFE SCIENCES
- Jason Li
- Chief Financial Officer
- MEDILINK THERAPEUTICS
- Meng Li
- Economist / Assistant Professor
- STIFEL FINANCIAL CORP / TUFTS UNIVERSITY
- Song Li
- Head of Innovative Drugs
- Matwings
- Alex Lu
- Chief Executive Officer, China
- BRIOHEALTH SOLUTIONS
- Bai Lu
- Professor
- FUDAN UNIVERSITY
- Qiang Lu
- Co-Founder & Chairman
- GENFLEET THERAPEUTICS
- Frank Nestle
- Partner and Chief Executive Officer
- DEERFIELD, 3DC
- Fei Pu
- Director & General Manager
- LEPU MEDICAL TECHNOLOGY
- Ioannis Sapountzis
- Chief Executive Officer & Chairman
- BOEHRINGER INGELHEIM CHINA
- Wei Sha
- Chief Executive Officer
- VYBIO
- Fei Shen
- Head of BD&L USA & Global TA Inflammation
- BOEHRINGER INGELHEIM
- Yonghui Shi
- Executive Director, Senior Vice President
- MICROTECH MEDICAL
- Jeffrey Su
- Chief Executive Officer
- MARINA BIOTHERAPEUTICS
- Lanny Sun
- Chief Executive Officer & Chairman
- FULL-LIFE TECHNOLOGIES
- John Wang
- Senior Vice President of Small Molecule Drug Discovery and Technology
- XTALPI
- Lai Wang
- President, Global Head of R&D
- BEONE
- Wilson Wang
- Head of Corporate Development
- CREATERNA
- Michael Wen
- Co-President
- HANGZHOU TIGERMED CONSULTING
- Jane Wu
- Managing Director
- JP MORGAN
- Marietta Wu
- Managing Director
- QUAN CAPITAL
- Richard Xie
- Senior Health Economist
- RA CAPITAL MANAGEMENT
- Cindy Xiong
- Partner
- FORESITE CAPITAL
- Jing Xu
- Vice President, Head of Global Strategy
- SCIWIND BIOSCIENCES
- Wei Xu
- Chief Scientific Officer
- METIS TECHBIO
- Dajun Yang
- Chairman of the Board, Executive Director & Chief Executive Officer
- ASCENTAGE PHARMA
- Jenny Yang
- Head of External Innovation Asia Pacific
- NOVO NORDISK A/S
- Liyuan Yang
- Vice President ,Head of Business Development China
- BRISTOL MYERS SQUIBB
- Yingying Yang
- Partner
- QUAN CAPITAL
- Mao Yin
- Founder & Chief Scientific Officer
- PRIMELINK BIOTHERAPEUTICS
- Yu Yu
- Chief Executive Officer
- PLERYON THERAPEUTICS
- Yuan Yuan
- Head of Platform Development, China
- NEXTBIO CAPITAL
- Man Zhang
- Senior Vice President, Head of biology and translational medicine
- INSILICO MEDICINE
- Sean Zhang
- Executive Director
- VIVO CAPITAL
- Shuo Zhang
- Associate Portfolio Manager
- BALYASNY ASSET MANAGEMENT
- Weian Zhao
- Founder & Chief Executive Officer
- AUREKA BIOTECHNOLOGIES
- Yangbing Zhao
- President & Chief Scientific Officer
- UTC THERAPEUTICS
- Dan Zheng
- Head of Regional Innovation and Partnerships
- TAKEDA PHARMACEUTICALS
- Shengping Zhong
- Chief Executive Officer
- KINGSTRONBIO
- Jason Zhu
- Executive Director & Chief Executive Officer
- HENLIUS
- Jie Zhu
- Partner
- Wilson Sonsini Goodrich & Rosati
